Drug Type Small molecule drug |
Synonyms SP 20202, SP20202 |
Target |
Action antagonists |
Mechanism MR antagonists(Mineralocorticoid receptor antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedClinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic Nephropathies | Clinical | United States | - | |
| Heart Failure | Preclinical | United States | - |





